XOMA Royalty (XOMA) Assets Average (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Assets Average came in at $272.3 million in Q1 2026, up 25.47% year-on-year from $217.0 million in Q1 2025, and up 1.62% quarter-over-quarter from $267.9 million in Q4 2025.

XOMA Royalty (XOMA) Assets Average (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Assets Average across 16 years of filings, most recently posting $272.3 million for Q1 2026.

  • Assets Average for Q1 2026 came in at $272.3 million, up 25.47% year-over-year; the trailing twelve-month figure through Mar 2026 was $272.3 million (up 25.47% YoY), and the FY2025 annual result was $247.0 million, up 8.43% from the prior year.
  • Assets Average came in at $272.3 million for Q1 2026 at XOMA Royalty, up from $267.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $272.3 million in Q1 2026 to a low of $124.9 million in Q3 2023.
  • The 5-year median for Assets Average is $217.0 million (2025), against an average of $195.1 million.
  • Across the five-year window, Assets Average fell 17.25% in 2023 and surged 86.83% in 2024, its largest moves.
  • XOMA Royalty's Assets Average stood at $143.3 million in 2022, then rose by 25.09% to $179.2 million in 2023, then rose by 24.06% to $222.3 million in 2024, then rose by 20.52% to $267.9 million in 2025, then rose by 1.62% to $272.3 million in 2026.
  • The last three Assets Average figures came in at $272.3 million (Q1 2026), $267.9 million (Q4 2025), and $243.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 33.42 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 795.91 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 13.04 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 1.72 Bn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 40.89 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 26.03 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 10.06 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 26.06 Bn
9 Abivax 95.45 Bn 95.45 Bn - 660.38 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 272.28 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 272.28 Mn
Dec 31, 2025 267.92 Mn
Sep 30, 2025 243.30 Mn
Jun 30, 2025 218.10 Mn
Mar 31, 2025 217.01 Mn
Dec 31, 2024 222.31 Mn
Sep 30, 2024 233.31 Mn
Jun 30, 2024 231.35 Mn
Mar 31, 2024 226.86 Mn
Dec 31, 2023 179.20 Mn
Sep 30, 2023 124.88 Mn
Jun 30, 2023 129.66 Mn
Mar 31, 2023 137.02 Mn
Dec 31, 2022 143.26 Mn
Sep 30, 2022 150.18 Mn
Jun 30, 2022 156.69 Mn
Mar 31, 2022 162.86 Mn
Dec 31, 2021 148.53 Mn
Sep 30, 2021 133.13 Mn
Jun 30, 2021 127.82 Mn